长风药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
NMPA:5
Drug Approvals
Formoterol Fumarate Inhalation Solution
- Product Name
- 富马酸福莫特罗吸入溶液
- Approval Number
- 国药准字H20253076
- Approval Date
- Jan 8, 2025
NMPA
Terbutaline Sulfate Nebuliser Solution
- Product Name
- 硫酸特布他林雾化吸入用溶液
- Approval Number
- 国药准字H20234102
- Approval Date
- Sep 5, 2023
NMPA
Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray
- Product Name
- 氮䓬斯汀氟替卡松鼻喷雾剂
- Approval Number
- 国药准字H20223778
- Approval Date
- Nov 1, 2022
NMPA
Salbutamol Sulfate Inhalation Solution
- Product Name
- 吸入用硫酸沙丁胺醇溶液
- Approval Number
- 国药准字H20213807
- Approval Date
- Oct 26, 2021
NMPA
Budesonide Suspension for Inhalation
- Product Name
- 吸入用布地奈德混悬液
- Approval Number
- 国药准字H20213357
- Approval Date
- May 11, 2021
NMPA
Clinical Trials
No trials found
News
No news found